학술논문
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial.
Document Type
Article
Author
Siu, Lillian L.; Even, Caroline; Mesía, Ricard; Remenar, Eva; Daste, Amaury; Delord, Jean-Pierre; Krauss, Jürgen; Saba, Nabil F.; Nabell, Lisle; Ready, Neal E.; Braña, Irene; Kotecki, Nuria; Zandberg, Dan P.; Gilbert, Jill; Mehanna, Hisham; Bonomi, Marcelo; Jarkowski, Anthony; Melillo, Giovanni; Armstrong, Jon M.; Wildsmith, Sophie
Source
JAMA Oncology; Feb2019, Vol. 5 Issue 2, p195-203, 9p
Subject
Language
ISSN
23742437